期刊
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
卷 25, 期 8, 页码 1621-1629出版社
AMER SOC NEPHROLOGY
DOI: 10.1681/ASN.2013121300
关键词
-
资金
- National Institutes of Health Grants [R01-HL085757, R01-DK093770, P30-DK079310, K24-DK090203]
- National Institutes of Health [U01-DK082185]
Interest in developing and using novel markers of kidney injury is increasing. To maintain scientific rigour in these endeavors, a comprehensive understanding of statistical methodology is required to rigorously assess the incremental value of novel biomarkers in existing clinical risk prediction models. Such knowledge is especially relevant, because no single statistical method is sufficient to evaluate a novel biomarker. In this review, we highlight the strengths and limitations of various traditional and novel statistical methods used in the literature for biomarker studies and use biomarkers of AKI as examples to show limitations of some popular statistical methods.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据